Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 1111-1113

  Rayburg, Melissa ^a   Towbin, Alexander ^a   Yin, Hong ^a   Maugans, Todd ^a   Maurer, Barry ^b   Nagarajan, Rajaram ^a   Weiss, Brian ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Division of General and Community Pediatrics   (United States)

Author keywords

Fenretinide; LCH; Neuroblastoma; New agents; Pediatric oncology

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FENRETINIDE; HOMOVANILLIC ACID; IODINE 123; MELPHALAN; T6 ANTIGEN; TOPOTECAN; VANILMANDELIC ACID; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE LESION; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPLASTY; CREATININE URINE LEVEL; HISTIOCYTOSIS X; HUMAN; MALE; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL;

BONE NEOPLASMS; CHILD; FENRETINIDE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; NEUROBLASTOMA;

EID: 71049124468     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22200     Document Type: Article

References (18)

1. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:247-258. (Pubitemid 28175878)
2. Gasent Blesa JM, Alberola Candel V, Solano Vercet C, et al. Langerhans cell histiocytosis. Clin Transl Oncol 2008;10:688-696.
3. Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer Suppl 1994;23:S37-S40. (Pubitemid 24275537)
4. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease. N Engl J Med 1994;331:154-160. (Pubitemid 24209565)
5. Bhatia S, Nesbit ME, Jr., Egeler RM, et al. Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr 1997;130:774-784. (Pubitemid 27492616)
6. Broadbent V, Egeler RM, Nesbit ME, Jr. Langerhans cell histiocytosis-clinical and epidemiological aspects. Br J Cancer Suppl 1994;23:S11-S16. (Pubitemid 24275532)
7. Egeler RM, Thompson RC, Jr., Voute PA, et al. Intralesional infiltration of corticosteroids in localized Langerhans' cell histiocytosis. J Pediatr Orthop 1992;12:811-814.
8. Reynolds CP, Lie S. Retinoid therapy of neuroblastoma. In: Brodeur GM ST, Tsuchida Y, Voute PA, editors. Neuroblastoma. Amsterdam: Elseviere Science; 2000. pp. 519-540.
9. Reynolds CP, Matthay KK, Villablanca JG, et al. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 2003;197:185-192.
10. Maurer BJ, Kalous O, Yesair DW, et al. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-XSORB organized lipid complex. Clin Cancer Res 2007;13:3079-3086. (Pubitemid 46849585)
11. Drozynska E, Szolkiewicz A, Balcerska A, et al. Coexistent neuroblastoma and histiocytosis? Med Pediatr Oncol 2003;41:92-93.
12. Fischer A, Jones L, Lowis SP. Concurrent Langerhans cell histiocytosis and neuroblastoma. Med Pediatr Oncol 1999;32: 223-224. (Pubitemid 29095983)
13. Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23: 81-85. (Pubitemid 24213320)
14. Egeler RM, Neglia JP, Arico M, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998;12:369-378. (Pubitemid 28175886)
15. Egeler RM, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993;71:865-873. (Pubitemid 23051395)
16. Villablanca JG, Krailo MD, Ames MM, et al. Phase I trial of oral fenretinide in children with high-risk solid tumors: A report from the Children's Oncology Group (CCG 09709). J Clin Oncol 2006; 24:3423-3430.
17. Garaventa A, Luksch R, Lo Piccolo MS, et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 2003;9:2032-2039. (Pubitemid 36687622)
18. Nichols KE, Egeler RM, Perry VH, et al. Summary of the 12th Nikolas Symposium dendritic cell differentiation: Signals, signaling and functional consequences as clues to possible therapy. J Pediatr Hematol Oncol 2003;25:193-197.